/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

B

Brian M. Slomovitz

Mount Sinai Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

429

Papers

11.4K

Citations

45

h-index

124

i10-index

Brian M. Slomovitz is an academic researcher from Mount Sinai Medical Center. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Cervical Cancer and HPV Research. The author has an h-index of 45, co-authored 365 publications.

ORCID: 0000-0002-7241-3096

Research Topics

Endometrial and Cervical Cancer Treatments Ovarian cancer diagnosis and treatment Cervical Cancer and HPV Research Estrogen and related hormone effects Uterine Myomas and Treatments

Papers by this author

works

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer

2023 · New England Journal of Medicine · 718 citations

https://doi.org/10.1056/nejmoa2216334

Mansoor Raza Mirza Dana M. Chase Brian M. Slomovitz René dePont Christensen

Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma

2015 · Journal of Clinical Oncology · 312 citations

https://doi.org/10.1200/jco.2014.58.3401

Brian M. Slomovitz Yunyun Jiang Melinda S. Yates Pamela T. Soliman

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

2021 · Journal of Clinical Oncology · 116 citations

https://doi.org/10.1200/jco.21.00006

Maaike H.M. Oonk Brian M. Slomovitz Peter Baldwin Helena C. van Doorn

Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer

2023 · International Journal of Gynecological Cancer · 21 citations

https://doi.org/10.1136/ijgc-2022-004026

Breana L Hill Ryon P. Graf Kunal Shah Natalie Danziger

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

2024 · Journal of Clinical Oncology · 19 citations

https://doi.org/10.1200/jco-24-01887

Brian M. Slomovitz David Cibula Weiguo Lv Fırat Ortaç

Evolving treatment paradigms in metastatic or recurrent low-grade endometrial cancer: When is hormonal-based therapy the preferred option?

2023 · International Journal of Gynecological Cancer · 17 citations

https://doi.org/10.1136/ijgc-2023-004454

Haider Mahdi Isabelle Ray‐Coquard Domenica Lorusso Mansoor Raza Mirza

Research topics

topics

Endometrial and Cervical Cancer Treatments

Ovarian cancer diagnosis and treatment

Cervical Cancer and HPV Research

Estrogen and related hormone effects

Uterine Myomas and Treatments

Chat about Author

Papers

Chat

Click to start Chat